S&P 500
5,978.57
+0.7%
+$42.63
DJI
42,534.29
+0.5%
+$228.81
NASDAQ
19,446.45
+1.1%
+$203.84
Bitcoin
106,105.00
+1.8%
+1,886.24
AAPL
$203.15
+0.7%
+$1.45
AMZN
$207.49
+0.4%
+$0.84
GOOG
$169.38
-0.6%
-$0.99
META
$669.68
-0.2%
-$1.22
MSFT
$462.94
+0.2%
+$0.97
NVDA
$141.62
+3.1%
+$4.24
TSLA
$354.90
+3.6%
+$12.21
Bioqual (OTC: BIOQ)
$45.00
(-2.1%)
-$0.95
Price as of May 15, 2025, 9:54 a.m. ET
Bioqual Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Bioqual Company Info
Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. It focuses on animal models of human diseases including COVID-19, Zika, AIDS, Influenza, RSV, Malaria, and other infectious disease areas. The company was founded by John C. Landon on June 1, 1981 and is headquartered in Rockville, MD.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.